30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mark Rosenblum

Track

Insider profile

Currently holds positions in Activecare Inc and Salarius Pharmaceuticals Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Chief Executive Officer Activecare Inc Dec. 11, 2017 -
Interim Chief Financial Officer, Executive Vice President - Finance Salarius Pharmaceuticals Inc Sept. 13, 2019 -
Chief Financial Officer, Senior Vice President, Secretary Advaxis Inc Jan. 5, 2010 - March 24, 2014
Mark Rosenblum's trades of Salarius Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-20 2025-11-20
B Purchase
54,950 -32.0%
389.03
US$3,986,887 		54,950 -32.0% 389.03 US$3,986,887
2022-05-31 2022-05-31
B Purchase
42,410 +46.1%
491.85
US$3,987,817 		42,410 +46.1% 491.85 US$3,987,817
2022-03-09 2022-03-03
B Purchase
28,445 +6.4%
289.55
US$3,170,658 		28,445 +6.4% 289.55 US$3,170,658
2020-08-18 2020-08-17
B Purchase
5,000 +71.4%
1.00
US$5,000 		5,000 +71.4% 1.00 US$5,000
2020-02-20 2020-02-19
B Purchase
2,000 +40.0%
0.95
US$1,900 		2,000 +40.0% 0.95 US$1,900
2020-02-13 2020-02-13
B Purchase
5,000 +inf%
0.86
US$4,295 		5,000 +inf% 0.86 US$4,295
2013-10-28 2013-10-24
US Old Ayala Inc (AYLA)
B Purchase
12,000 +146.4%
4.00
US$48,000 		12,000 +146.4% 4.00 US$48,000